Magnetic nanoparticles of Fe3O4 enhance docetaxel-induced prostate cancer cell death
Akiko Sato,1 Naoki Itcho,1 Hitoshi Ishiguro,2,3 Daiki Okamoto,1 Naohito Kobayashi,4 Kazuaki Kawai,5 Hiroshi Kasai,5 Daisuke Kurioka,1 Hiroji Uemura,2 Yoshinobu Kubota,2 Masatoshi Watanabe11Laboratory for Medical Engineering, Division of Materials Science and Chemical Engineering, Graduate School of...
Guardado en:
Autores principales: | Sato A, Itcho N, Ishiguro H, Okamoto D, Kobayashi N, Kawai K, Kasai H, Kurioka D, Uemura H, Kubota Y, Watanabe M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dfc37ee36a814d64916bc6e0dd67e026 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An effective strategy for development of docetaxel encapsulated gold nanoformulations for treatment of prostate cancer
por: S. Thambiraj, et al.
Publicado: (2021) -
Docetaxel treatment in the elderly patient with hormone refractory prostate cancer
por: Victoria J Sinibaldi
Publicado: (2008) -
Docetaxel-titanate nanotubes enhance radiosensitivity in an androgen-independent prostate cancer model
por: C Mirjolet, et al.
Publicado: (2017) -
Impact of Serum γ-Glutamyltransferase on Overall Survival in Men with Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel
por: Minami Une, et al.
Publicado: (2021) -
Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer
por: Qi Wang, et al.
Publicado: (2017)